ftInvstr
LALPATHLAB · Healthcare ₹1895.0 -1.66% Mkt Cap ₹31757 Cr overvalued

LALPATHLAB

Healthcare Diagnostics & Research
₹1895.0
-1.66% today · 30d -1.68%
as of 2026-09-04
Price · Daily Candles
“Dr. Lal PathLabs' Net Profit Dips by 14.98% QoQ Amidst FII Sell-off and Q4 Revenue Growth.”
Dr. Lal PathLabs, valued at ₹26,783 Cr, faces a notable challenge as its quarterly net profit dropped by 14.98% YoY despite a 16.61% YoY revenue increase in Q4 2026. The stock trades at a TTM PE of 50.68, contrasting with its 3-year net profit CAGR of 28.75%, yet its Free Cash Flow (FCF) growth predictions are弱.
BULL CASE
+Q4 2026 revenue increased by 16.61% YoY to ₹703 Cr, demonstrating consistent top-line growth.
+Annual revenue for FY26 grew by 12.25% to ₹2,763 Cr, with a strong 3-year net profit CAGR of 28.75%.
+Promoters maintain a significant stake of 53.21% as of March 2026, indicating confidence.
+The company demonstrated a 1:1 bonus share issue on December 19, 2025, reflecting returns to shareholders.
BEAR CASE
Net profit in Q4 2026 decreased by 14.98% YoY to ₹132 Cr, despite revenue growth.
Operating Profit Margin (OPM) declined by 1.99% YoY in Q4 2026.
Foreign Institutional Investors (FIIs) reduced their stake by 3.11% QoQ, bringing it to 17.18% in March 2026.
The stock is trading at a high TTM PE of 50.68 and a PB of 11.21, significantly above its historical averages.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹703 Cr
+16.61% YoY
NET PROFIT
₹132 Cr
-14.98% YoY
OPM
29.01%
-1.99pp YoY
EPS
₹7.86
PE 50.68
Intrinsic value · DCF ₹497.97 · Margin of safety -73.7% (overvalued) · FCF yield 1.48%
◇ Sector Position
Dr. Lal PathLabs' TTM PE of 50.68 is lower than Vijaya Diagnostic Centre (74.93) but higher than Thyrocare's 49.03, while its ROCE of 28.0% is competitive against Sailife (18.42%) and Metropolis (20.67%).
PEERPEROCE %
LALPATHLAB50.6828.0
SAILIFE69.3718.42
SYNGENE59.0321.22
VIJAYA74.9326.15
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
66
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth STEADY 63
Profitability HIGH 92
Technicals NEUTRAL 67
Risk LOW 80
Key Stats
TTM PE
50.68
P/B
11.21
52W HIGH
₹1988.9
OFF HIGH
-4.72%
DIV YIELD
0.87%
MKT CAP
₹31757 Cr
◉ Active Signals
MACDNeutral-8.7649
RSI(14)Neutral51.39
Near 52W HighBullish-4.72
Street Consensus
26 analysts
₹1686.0
mean target
Low ₹1180.0Now ₹1895.0High ₹2072.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold LALPATHLAB and at what entry.

Sign up freeSign in